Skip to main content
SpringerLink
Log in

Prospective cytomegalovirus surveillance in paediatric renal transplant patients

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Fifty-eight consecutive paediatric recipients of 65 renal transplants were prospectively studied for up to 72 months for evidence of cytomegalovirus (CMV) infection. Blood, urine and saliva were screened for CMV pre transplant and then weekly for the first 6 weeks, and monthly thereafter, by conventional cell culture and by detection of early antigen flourescent foci. Donor CMV serostatus was available in 51 cases. All patients received triple therapy as immunosuppression and none had CMV prophylaxis. Twenty-six episodes of CMV infection (40% of transplants) and 10 of CMV disease (15%) were identified. Donor CMV seropositivity, regardless of recipient CMV serostatus, was significantly associated with CMV infection (P=0.04). First CMV excretion was significantly earlier in patients who subsequently became symptomatic than in those who did not (P=0.04), and a positive blood culture was significantly associated with CMV disease (P=0.04). We found no association between extra anti-rejection treatment or recipient's age and CMV infection or disease. CMV disease had no influence on renal function as assessed by glomerular filtration rate at 6, 12 and 24 months post transplant, nor on graft loss. CMV disease was fatal in 1 patient. We conclude that trials of CMV prohpylactic agents are indicated, particularly in recipients of CMV seropositive grafts. A positive blood culture should lead to consideration of anti-CMV therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Balfour H, Chase BA, Stapelton JT, Simmons RL, Fryd DS (1989) A randomized, placebo trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381–1387

    PubMed  Google Scholar 

  2. Chou S, (1986) Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N Engl J Med 314:1418–1423

    PubMed  Google Scholar 

  3. Dummer JS, White LT, Ho M, Griffith BP, Hardesty RL, Bahnson HT (1985) Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis 152:1182–1191

    PubMed  Google Scholar 

  4. Fox AS, Tolpin MD, Baker AL, Broelsch CE, Whittington PF, Jackson T, Thistlethwaite JR, Stuart FP (1988) Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis 157:383–385

    PubMed  Google Scholar 

  5. Gorensek MJ, Stewart RW, Keys TF, Mc Henry MC, Goormastic M (1988) A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients. J Infect Dis 157:515–522

    PubMed  Google Scholar 

  6. Gorensek MJ, Carey WD, Vogt D, Goormastic M (1990) A multivariate analysis of risk factors for cytomegalovirus infection liver-transplant recipients. Gastroenterology 98:1326–1332

    Google Scholar 

  7. Grundy JE, Super M, Sweny P, Moorhead J, Lui SF, Berry NJ, Fernando ON, Griffiths PD (1988) Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactiation of recipient virus. Lancet II 132–135

    Google Scholar 

  8. Harmon WE (1991) Opportunistic infections in children following renal transplantation. Pediatr Nephrol 5:118–125

    PubMed  Google Scholar 

  9. Van Son WJ, The TH (1989) Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation. Transplant Int 2:147–164

    Google Scholar 

  10. Hibberd PL, Rubin RH (1991) Prevention of cytomegalovirus infection in the pediatric renal transplant recipient. Pediatr Nephrol 5: 112–117

    PubMed  Google Scholar 

  11. Pass RF, Whitley RJ, Dethelm AG, Whelchel JD, Reynolds DW, Alford CA (1980) Cytomegalovirus infection in patients with renal transplants. J Infect Dis 142:9–17

    PubMed  Google Scholar 

  12. Pollard RB (1988) Cytomegalovirus in renal, heart, heart-lung and liver transplantation. Pediatr Infect Dis J 7:S97-S102

    PubMed  Google Scholar 

  13. Snydman DR, Werner BG, Heince-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL, Levey AS, Strom TB, Carpenter CB, Levey RH, Harmon WE, Zimmerman CE, Shapiro ME, Steinman T, Lo Gerfo F, Idelson B, Schroter GPJ, Levin MJ, Mc Iver J, Leszczynski J, Grady GF (1987) Use of cytomegalovirus immune globuline to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317:1049–1054

    PubMed  Google Scholar 

  14. Pillay D, Charman H, Burroughs AK, Smith M, Rolles K, Griffiths PD Surveillance for cytomegalovirus infection in orthoptic liver transplant recipients. Transplantation (in press)

  15. Berry NJ, Grundy JE, Griffiths PD (1986) An improved radio immuno assay method for detection of IgG antibodies against CMV. J Virol Methods 13:343–350

    PubMed  Google Scholar 

  16. Griffiths PD, Stirk PD, Ganczakowski M, Panjwani DD, Ball MG, Blalock HA, Prentice HG (1984) Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet II: 1242–1244

    Google Scholar 

  17. Stirk PR, Griffiths PD (1987) Use of monoclonal antibodies for the diagnosis of CMV infection by Deaff in cell culture. J Med Virol 21: 329–337

    PubMed  Google Scholar 

  18. Fryd DS, Peterson PK, Ferguson RM, Simmons JS, Balfour HH, Najarian JS (1980) Cytomegalovirus as a risk factor in renal transplantation. Transplantation 30:436–439

    PubMed  Google Scholar 

  19. Bowden RA, Sayers M, Fournoy N, Newton B, Banaji M, Thomas ED, Meyers JD (1986) Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantations. N Engl J Med 314: 1006–1010

    PubMed  Google Scholar 

  20. Peterson PK, Balfour HH, Marker SC, Fryd DS, Howard RJ, Simmons RL (1980) Cytomegalovirus disease in renal allograft recipient: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 59:283–300

    Google Scholar 

  21. Ranjan D, Burke G, Esquenazi V, Milgrom M, Koleilat N, Roth D, Gomez C, Olson L, Babischkin S, Gharagozloo H, Miller J (1991) Factors affecting the ten-year outcome of human renal allografts. Transplantation 5:113–117

    Google Scholar 

  22. Stratta RJ, Shaefer MS, Cushing KA, Mark RS, Wood RP, Lagnas AN, Reed EC, Wood GL, Donovan JP, Pillen TJ, Li S, Duckworth RM, Shaw BW (1989) Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients. Transplantation 51:90–97

    Google Scholar 

  23. Rakela J, Wiesner RH, Taswell HF, Hermans PE, Smith TF, Perkins JD, Krom RAF (1987) Incidence of cytomegalovirus infection and its relationship to donor-recipient serological status in liver transplantation. Transplant Proc 19:2399–2402

    PubMed  Google Scholar 

  24. Velasco N, Catto GRD, Edward N, Engeset J, Moffat MAJ (1984) The effect of the dosage of steroids on the incidence of cytomegalovirus infection in renal transplant recipients. J Infect 9:69–78

    PubMed  Google Scholar 

  25. Breinig MK, Zitelli B, Starzl TE, Ho M (1987) Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 156: 273–279

    PubMed  Google Scholar 

  26. Dussaix E, Wood C (1989) Cytomegalovirus infection in pediatric liver recipients. Transplantation 48:272–274

    PubMed  Google Scholar 

  27. Dowling IN, Saslow AR, Armstrong JA, Ho M (1976) Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders. J Infect Dis 133:399–407

    PubMed  Google Scholar 

  28. Rubin RH, Cosimi AB, Tolkoff-Rubin NE, Russell PS, Hirsch MS (1977) Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation. 24:458–464

    PubMed  Google Scholar 

  29. Schmidt GH, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA (1991) A randomized controlled trial of prophylactic for cytomegalovirus pulmonary infection in recipients of allogenic bone marrow transplants. N Engl J Med 324:1005–1012

    PubMed  Google Scholar 

  30. Marker SC, Howard RJ, Simmons RL, Kalis JM, Connelly DP, Najarian JS, Balfour HH (1981) Cytomegalovirus infection: a quantitative prospective study of three hundred and twenty consecutive renal transplants. Surgery 89:660–671

    PubMed  Google Scholar 

  31. Dunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH, Fletcher CV, Bolman RM, Matas AJ, Payne WD, Sutherland DER, Najarian JS (1991) Treatment of invasive cytomegalovirus disease in solid organ transplant patients with gancyclovir. Transplantation 51:98–106

    PubMed  Google Scholar 

  32. Hecht DW, Snydman DR, Crumpacker CS, Werner BG, Heinze-Lacey B (1988) Gancyclovir for treatment of renal transplant associated primary cytomegalovirus pneumonia. J Infect Dis 157: 187–190

    PubMed  Google Scholar 

  33. Van Den Berg AP, Van Der Bij W, Van Son WJ, Anema J, Van Der Giessen M, Schirm J, Tegzess AM, The TH (1989) Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation — a report of 130 consecutive patients. Transplantation 48:991–995

    PubMed  Google Scholar 

  34. Griffiths PD, Grundy JE, Ali A, Sweny P, Trompeter RS, Fernando ON, Moorhead J (1988) Cytomegalovirus matching in renal transplantation. Lancet II:971

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics and Division of Communicable Diseases, Royal Free Hospital School of Medicine, Rowland Hill Street, NW3 2PF, London, UK

    S. Iragorri, D. Pillay, M. Scrine, R. S. Trompeter, L. Rees & P. D. Griffiths

Authors
  1. S. Iragorri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Pillay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Scrine
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. S. Trompeter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Rees
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. D. Griffiths
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iragorri, S., Pillay, D., Scrine, M. et al. Prospective cytomegalovirus surveillance in paediatric renal transplant patients. Pediatr Nephrol 7, 55–60 (1993). https://doi.org/10.1007/BF00861569

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00861569

Key words

Search

Navigation